Liver resection for hepatic Haemangioma

Background: Hepatic hemangiomas are the most common benign liver tumors, often presenting management challenges. While many remain asymptomatic, some cause significant symptoms or complications, necessitating surgical intervention.Aim: To investigate the indications and clinical outcomes of liver resection for hepatic hemangioma at the National Liver Institute - Menoufia University.Methods: This retrospective study analyzed 45 patients who underwent liver resection for hepatic hemangioma from November 2019 to November 2023. Data collected included demographics, clinical presentation, imaging findings, surgical details, and postoperative outcomes.Results: The study included 45 patients (84.4% female, 15.6% male) with a mean age of 41±9 years. The most common symptom was right hypochondrial pain (53.3%). Imaging revealed right lobe hemangiomas in 68.9% of cases. Non-anatomical resection was the most common surgical procedure (42.2%). Postoperative complications were minimal, with 93.3% of patients experiencing no complications. Pain improvement was reported by 95.6% of patients after three months. Significant changes in liver function tests were observed postoperatively, including decreases in albumin (3.969 to 3.493 g/dL, p=0.029), increases in ALT (44.64 to 166.09 U/L, p<0.001) and AST (39.44 to 142.53 U/L, p<0.001), and changes in coagulation parameters (INR increased from 1.00 to 1.164, p<0.001).Conclusion: Liver resection for hepatic hemangiomas is generally safe and effective, with high rates of symptom improvement and manageable postoperative changes in liver function. While most patients experienced no complications, the observed changes in liver function parameters underscore the need for careful postoperative monitoring. These findings support surgical intervention as a viable option for symptomatic hepatic hemangiomas.